1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Anti-Rheumatics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Prescription-based Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Over-the-Counter Drugs
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Disease Modifying Anti-Rheumatics Drugs (DMARD's)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Corticosteroids
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Uric Acid Drugs
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Route of Drug Administration
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Parenteral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 E-Commerce
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Amgen Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biogen Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Bristol-Myers Squibb Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Celltrion Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Eli Lilly and Company
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 F. Hoffmann-La Roche AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Johnson & Johnsons
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sanofi SA
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Anti-Rheumatics Market: Major Drivers and Challenges
Figure 2: Global: Anti-Rheumatics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Anti-Rheumatics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Anti-Rheumatics Market: Breakup by Type (in %), 2023
Figure 5: Global: Anti-Rheumatics Market: Breakup by Drug Class (in %), 2023
Figure 6: Global: Anti-Rheumatics Market: Breakup by Route of Drug Administration (in %), 2023
Figure 7: Global: Anti-Rheumatics Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Anti-Rheumatics Market: Breakup by Region (in %), 2023
Figure 9: Global: Anti-Rheumatics (Prescription-based Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Anti-Rheumatics (Prescription-based Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Anti-Rheumatics (Corticosteroids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Anti-Rheumatics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Anti-Rheumatics (Uric Acid Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Anti-Rheumatics (Uric Acid Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Anti-Rheumatics (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Anti-Rheumatics (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Anti-Rheumatics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Anti-Rheumatics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Anti-Rheumatics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Anti-Rheumatics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Anti-Rheumatics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Anti-Rheumatics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Anti-Rheumatics (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Anti-Rheumatics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Anti-Rheumatics (E-Commerce) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Anti-Rheumatics (E-Commerce) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: North America: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: North America: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: United States: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: United States: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Canada: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Canada: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Asia-Pacific: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Asia-Pacific: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: China: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: China: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Japan: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Japan: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: India: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: India: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: South Korea: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: South Korea: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Australia: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Australia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Indonesia: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Indonesia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Europe: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Europe: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Germany: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Germany: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: France: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: France: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: United Kingdom: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: United Kingdom: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Italy: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Italy: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Spain: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Spain: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Russia: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Russia: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Latin America: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Latin America: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Brazil: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Brazil: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Mexico: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Mexico: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Others: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Middle East and Africa: Anti-Rheumatics Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Middle East and Africa: Anti-Rheumatics Market: Breakup by Country (in %), 2023
Figure 83: Middle East and Africa: Anti-Rheumatics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Global: Anti-Rheumatics Industry: SWOT Analysis
Figure 85: Global: Anti-Rheumatics Industry: Value Chain Analysis
Figure 86: Global: Anti-Rheumatics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Anti-Rheumatics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Anti-Rheumatics Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Anti-Rheumatics Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 4: Global: Anti-Rheumatics Market Forecast: Breakup by Route of Drug Administration (in Million US$), 2024-2032
Table 5: Global: Anti-Rheumatics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Anti-Rheumatics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Anti-Rheumatics Market: Competitive Structure
Table 8: Global: Anti-Rheumatics Market: Key Players